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It is therefore of fundamental importance that irregular immune responses to drug carriers are understood to ensure their future rational design and evaluation. For example, there is no known clinical or laboratory test at present that can predict pseudoallergic reactions to advanced formulations among individual subjects. The above-mentioned drugs are widely used despite their reactogenicity, probably because in cancer chemotherapy, their indication area, there is more tolerance for side effects.
By providing a comprehensive and thorough analysis of the above irregular immune responses to drug-carrier systems, the present articles will increase our awareness of these phenomena and inspire new concepts for the further development of this field. I would like to express my appreciation and gratitude to the Editor-In-Chief, Dr. Stephen Bruck, for recognizing the novelty and importance of this subject and for giving me the opportunity to be a guest editor for this topical issue.
Janos Szebeni, M.D., Ph.D.
We will miss him … T   passing away of Dr. Stephen Bruck is a great loss for his family, the publisher and readership of this journal, as well as for the scientific community as a whole. Personally, I am mourning a distinguished mentor and supporter, a dear senior friend. Our common professional interests and his Austro-Hungarian roots, feeding a keen interest in Hungarians and their affairs, earned me unique opportunities to spend time and learn about him. Much could be told about the life of this man of extraordinarily broad knowledge and intense curiosity, underlying his devotion to and precision in editing this journal. Nevertheless, what I admired most in him was his youthful spirit and optimism in engaging in a variety of endeavors that would challenge the energy of people half of his chronological age. This openness and enthusiasm for science and many other arts of life make his premature death all the more tragic. He will remain in my memory as an ever-young man of boundless horizon, as I knew him.
J.S.
